359801-19-7 Usage
General Description
4-(4-BENZYLPIPERAZIN-1-YLMETHYL)BENZOIC ACID is a chemical compound with the molecular formula C20H22N2O2. It belongs to the class of organic compounds known as benzene and substituted derivatives. These are aromatic compounds containing one monocyclic ring system, where the ring is benzene. The specific properties of this chemical such as melting point, boiling point, density, and solubility would depend on its precise structure and the presence of other functional groups. Its potential applications can range based on its reactivity and other chemical characteristics. However, there is currently limited detailed information available on 4-(4-benzylpiperazin-1-ylmethyl)benzoic acid, including its potential uses and toxicity.
Check Digit Verification of cas no
The CAS Registry Mumber 359801-19-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,9,8,0 and 1 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 359801-19:
(8*3)+(7*5)+(6*9)+(5*8)+(4*0)+(3*1)+(2*1)+(1*9)=167
167 % 10 = 7
So 359801-19-7 is a valid CAS Registry Number.
InChI:InChI=1/C19H22N2O2/c22-19(23)18-8-6-17(7-9-18)15-21-12-10-20(11-13-21)14-16-4-2-1-3-5-16/h1-9H,10-15H2,(H,22,23)
359801-19-7Relevant articles and documents
Permeability of novel 4′-N-substituted (aminomethyl) benzoate-7-substituted nicotinic acid ester derivatives of scutellarein in Caco-2 cells and in an in vitro model of the blood-brain barrier
Ou, Yu,Luo, Min,Dong, Yong-Xi,Su, Hang,Fu, Xiao-Zhong,Cha, Yu-Feng,Zhang, Shun,Zhao, Yong-Long,Li, Yong-Jun,Wang, Yong-Lin
, p. 2205 - 2213 (2016)
A series of 4′-N-substituted (aminomethyl) benzoate-7-substituted nicotinic acid ester derivatives of scutellarein was designed and synthesized. Evaluation of physiochemical properties showed that the newly designed compounds had greater chemical stability and aqueous solubility than scutellarin or scutellarein. The permeabilities (Papp AP to BL) of compounds 7b and 7e in Caco-2 cells were 5.9-fold and 3.7-fold higher than that of scutellarin, and 3.7-fold and 2.4-fold higher than that of scutellarein. The permeabilities (Papp AP to BL) of compounds 7b and 7e in an in vitro model of the blood–brain barrier were 9.7-fold and 5.9-fold higher than that of scutellarin, and 9.2-fold and 5.6-fold higher than that of scutellarein.